ArticleActa parasitologica2025
Administration of Trichinella spiralis Antigens Alleviated Diabetic Nephropathy in Diabetic Mice.
Article in Acta parasitologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic nephropathy (DN) is a leading cause of end-stage renal disease (ESRD) among individuals with diabetes, highlighting the urgent need for effective therapeutic strategies to combat this condition. Prior research has indicated that T. spiralis possesses hypoglycemic properties. In this investigation, we aimed to evaluate the efficacy of T. spiralis antigens, derived from both adult and larval forms, in treating diabetic nephropathy in alloxan-induced diabetic mice (AIDM).
methodsA total of forty Swiss albino mice were allocated into four groups, each consisting of ten mice. Diabetes was induced in three of the groups using alloxan, while one group served as a control without diabetes. Two diabetic groups received treatment with either crude larva (CLA) antigen or adult worm antigen (AWA), while one group remained untreated. The study assessed various parameters, including fasting blood glucose levels, blood urea, serum creatinine, and serum albumin across all groups. Additionally, histopathological examinations of the kidneys were conducted.
resultsThe results indicated that treatment with CLA or AWA antigens led to a significant reduction in blood glucose, serum creatinine, and blood urea levels, alongside an increase in serum albumin. Notably, the administration of AWA antigens resulted in substantial improvements in renal pathological changes induced by diabetes, as evidenced by hematoxylin and eosin staining and Masson trichrome staining, which also demonstrated a reduction in fibrosis.
conclusionsThe findings suggest that T. spiralis antigens may mitigate renal damage in diabetic mice by alleviating hyperglycemia-induced inflammation and oxidative stress, warranting further investigation into their potential role in preventing DN in diabetic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.